Besides, Cavin3 is a part of the mTOR pathway, thus clarifying the effect of Cavin3 on lung cancer occurrence and development which might make it possible for the mTORC1 pathway to be a novel regulatory target in lung cancer [15–17]. This evidence concerns the gene CAVIN3 and lung cancer.